By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jul 3, 2016/Clinical Summary
PTs have a role in screening, examining, and providing intervention with this patient population in order to help minimize deleterious effects of bedrest and optimize movement.
Mar 26, 2021/CPG
Contains updated findings and recommendations including the use of non-fasting lipid determination as a suitable alternative to fasting levels.
Jul 24, 2016/Test & Measure
Assesses self-care, mobility, and social functioning in children aged 6 months to 7 years.
Jan 1, 2022/CPG
This guideline, from the New Zealand government, is for people with autism spectrum disorder (ASD), their families and carers, health and disability professionals, community supporters, employers, policy advisers, and anyone involved in education. Recommendations address diagnosis and initial assessment,
May 1, 2020/CPG
Recommendations, updated in 2020, from the American Association of Clinical Endocrinologists and American College of Endocrinology on the diagnosis, evaluation, and treatment of postmenopausal osteoporosis for endocrinologists, physicians, regulatory bodies, health-related organizations, and interested
Nov 30, 2017/Test & Measure
Used for patients with suspected delirium.
Jun 28, 2017/Test & Measure
Used during systems review to identify cognitive impairment in various patient populations.
Aug 14, 2017/Test & Measure
The PAR-Q was developed in an effort to standardize activity screening for persons aged 15-69 years.
Jun 29, 2017/Test & Measure
A 13-item questionnaire designed to provide both a patient and a caregiver report of the quality of life (QOL) for patients who have been diagnosed with Alzheimer Disease (AD).
May 11, 2024/CPG
Lower extremity peripheral artery disease is a common cardiovascular disease that is associated with significant morbidity, mortality and quality of life impairment. This collaborative guideline is an update of the 2016 guideline and provides new evidence to guide clinicians. Recommendation # 6 specifically